About the journal
Atherosclerosis Supplements is a journal published by Elsevier BV in Netherlands. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1878-5050 · 1567-5688
- Country
- Netherlands
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
- Official website
- https://www.journals.elsevier.com/atherosclerosis
Index listings
- PUBMED · 2005-12-15
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Dormant — no works recorded since 2020
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
13639
Last recorded publication year
2020
h-index
62
i10-index
341
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2020
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
Identity & continuity3
- Alternate titles
- Atherosclerosis supplements
- Source type
- journal
- Society affiliations
- European Atherosclerosis Society
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Cardiovascular Disease and Adiposity
- Cardiovascular Disease and Adiposity
- Atherosclerosis and Cardiovascular Diseases
- Atherosclerosis and Cardiovascular Diseases
Show all subjects (50)
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Adipokines, Inflammation, and Metabolic Diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Cholesterol and Lipid Metabolism
- Cholesterol and Lipid Metabolism
- Diet and metabolism studies
- Diet and metabolism studies
- Lipid metabolism and disorders
- Lipid metabolism and disorders
- Adipose Tissue and Metabolism
- Adipose Tissue and Metabolism
- Hormonal Regulation and Hypertension
- Hormonal Regulation and Hypertension
- Peroxisome Proliferator-Activated Receptors
- Peroxisome Proliferator-Activated Receptors
- Cerebrovascular and Carotid Artery Diseases
- Cerebrovascular and Carotid Artery Diseases
- Diet, Metabolism, and Disease
- Diet, Metabolism, and Disease
- Cardiac Imaging and Diagnostics
- Cardiac Imaging and Diagnostics
- Cardiovascular Health and Disease Prevention
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Health and Disease Prevention
- Antiplatelet Therapy and Cardiovascular Diseases
- Nutrition, Genetics, and Disease
- Nutrition, Genetics, and Disease
- Diabetes and associated disorders
- Diabetes and associated disorders
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- Eicosanoids and Hypertension Pharmacology
- Eicosanoids and Hypertension Pharmacology
- Fatty Acid Research and Health
- Fatty Acid Research and Health
- Nutritional Studies and Diet
- Nutritional Studies and Diet
- Systemic Lupus Erythematosus Research
- Systemic Lupus Erythematosus Research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ